Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: claudication major surgical or invasive procedure: peripheral angiography and stent placement in left superficial femoral artery history of present illness: pt is a yo man with htn, hyperlipidemia, pvd, experienced as pain in both calves when walking one block and resolving with rest, who presented for stenting of his femoral artery. he had abis which were also diminished bilaterally (0.82 right ankle, 0.66 left ankle). lower extremity doppler evaluation showed triphasic waveforms in bilateral common femoral arteries and evidence of a left sfa occlusion. past medical history: 1. pvd-s/p atherectomy and stenting of left sfa 2. bilateral renal artery stenosis 3. hyperlipidemia 4. hypertension 5. knee and hip replacement surgeries 6. s/p ppm social history: lives alone in in . one son. 50 pack year history of smoking quit 50 yrs ago. drinks accasional highball. retired from construction work. family history: mother with mi in 40's. physical exam: afebrile 145/60 64 12 99% on ra nad. alert. op clear with mmm. l carotid upstroke diminished with bilateral bruits. rrr soft s1, normal s2. soft systolic murmurs at rusb and llsb. no rubs or gallops lungs clear to auscultation abd is soft ntnd. normal bs. no bruits r groin without minimal ecchymoses no hematoma. no bruit and 1+ pulse. no peripheral edema. bilateral le warm. pertinent results: catheterization: brief history: yo man with hypertension and dyslipidemia referred for peripheral arteriography to evaluate significant bilateral leg claudication (l>r). he had abis which were also diminished bilaterally (0.82 right ankle, 0.66 left ankle). lower extremity doppler evaluation showed triphasic waveforms in bilateral common femoral arteries and evidence of a left sfa occlusion. indications for catheterization: peripheral vascular disease, claudication, positive noninvasive ischemia evaluation procedure: peripheral catheter placement was performed via the rfa. peripheral imaging was performed of the aa and bilateral le. peripheral pta was performed of the r sfa. peripheral stenting was performed of the r sfa. peripheral atherectomy was performed of the r sfa. **ptca results lsfa **baseline stenosis pre-ptca 100 **technique ptca sequence 1 guiding cath guidewires spatraco initial balloon (mm) 3.0 final balloon (mm) 6.0 # inflations 7 max pressure (psi) 120 **result stenosis post-ptca 0 success? (y/n) y ptca comments: initial angiography revealed a 70% lesion at the origin of the sfa and a mid-segment occlusion of the sfa in the left lower extremity. heparin was started prophylactically. a 7 french sheath was advanced into the left cfa. the total occlusion of the left sfa was crossed with moderate difficuly using a shinobi wire followed by an angled stiff glidewire. atherectomy was performed on th eproximal sfa using a silverhawk ls device with good result. we were unable to deliver the silverhawk device distal to the total occlusion, so the occlusion was dilated with a 3.0 x 20 mm saavy balloon using 3 inflations of 6 atm. we were still unable to deliver the atherectomy device so the diecsion was made to proceed with stenting of the left sfa. a 7.0 x 56 mm dynalink stent was deployed across the lesion and a 4.0 x 60 mm saavy balloon was used to dilate the stent at 120 atm. angiography demonstrated a filling defect at the proximal edge of the stent so a 7.0 x 100 mm dynalink stent was deployed proximal to the first stent in overlapping fashion and both stents were dilated with the 4.0 x 60 mm balloon using 3 inflations of 6 atm. final angiography revealed no residual stenosis, no apparent dissection, and normal flow. technical factors: total time (lidocaine to test complete) = 1 hour 13 minutes. arterial time = 1 hour 13 minutes. fluoro time = 29 minutes. contrast: non-ionic low osmolar (isovue, optiray...), vol 214 ml premedications: asa 325 mg p.o. anesthesia: 1% lidocaine subq. anticoagulation: heparin 5000 units iv other medication: fentanyl 50 mcg iv cardiac cath supplies used: - , angled glidewire, 180 .014 guidant, /core, 130cm .014 cordis, shinobi, 300cm 7f cook, , 55 7f foxhollow, silverhawk es 7 guidant, dynalink 56, 80 7 guidant, dynalink .018, 100 comments: 1. access was obtained in retrograde fashion via the rfa using a 6 french short sheath. 2. resting hemodynamics revealed no significant pressure gradient between ao and either common femoral artery. 3. abdominal aortography revealed nild diffuse athersclerotic disease. 4. the renal arteries were single bilaterally. the left renal artery had a 70% proximal stenosis and minimal blush was noted in the left kidney. the right renal artery had a proximal 70% stenosis. 5. selective angiography of the right lower extremity revealed no significant disease in the cia or eia. the sfa was subtotally occluded at the adductor. the popliteal had no significant disease. the at and pt were occluded with the pa filling the foot. 6. selective angiography of the left lower extremity revealed no significant disease in the cia or eia. there were mild luminal irreguarities in the cfa. the sfa was totally occluded in its mid segment and reconstituted just above the popliteal artery. the popliteal artery was not obstructed. 7. successful atherectomy of the proximal left sfa (see pta comments). 8. successful pta and stenting of the mid sfa with overlapping 7.0 x 100 mm and 7.0 x 56 mm dynalink stents which were postdilated with a 6.0 mm balloon. final angiography revealed no residual stenosis, no apparent dissection and normal flow (see pta comments). final diagnosis: 1. bilateral sfa and infrapopliteal disease. 2. bilateral renal artery stenosis. 3. successful atherectomy, pta, and stenting of the left sfa. . . right femoral vascular ultrasound: right common femoral artery and common femoral vein are widely patent, without pseudoaneurysm or av fistula. no large hematoma is identified within the soft tissues of the right groin. impression: no evidence of pseudoaneurysm, av fistula or hematoma within the right groin. brief hospital course: pt was taken to the catheterization lab and a stent was placed in the left superficial femoral artery. at the end of the procedure it was very difficult to attain hemostasis at the right groin access site. as there was concern for development of hematoma or pseudoaneurysm, pt was admitted to the ccu where he was monitored closely and had multiple stable hematocrit checks. a femoral vascular ultrasound was performed at the right groins site and showed neither pseudoaneurysm or hematoma. pt was stable and was discharged to home with plan to return at a later date for stenting of the right femoral artery. medications on admission: 1. nitroglycerin 0.3 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual q5min () as needed for chest pain. 2. amlodipine besylate 5 mg tablet sig: two (2) tablet po daily (daily). 3. prazosin hcl 5 mg capsule sig: one (1) capsule po hs (at bedtime). 4. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 5. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 6. metoprolol tartrate 50 mg tablet sig: two (2) tablet po bid (2 times a day). 7. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 9. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 10. tolterodine tartrate 2 mg tablet sig: one (1) tablet po bid (2 times a day). discharge medications: 1. nitroglycerin 0.3 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual q5min () as needed for chest pain. 2. amlodipine besylate 5 mg tablet sig: two (2) tablet po daily (daily). 3. prazosin hcl 5 mg capsule sig: one (1) capsule po hs (at bedtime). 4. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 5. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 6. metoprolol tartrate 50 mg tablet sig: two (2) tablet po bid (2 times a day). 7. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 9. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po daily (daily) for 30 days. 10. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 11. tolterodine tartrate 2 mg tablet sig: one (1) tablet po bid (2 times a day). 12. outpatient lab work please check potassium, bun, creatinine and call into nurse practitioner at () - . 1. nitroglycerin 0.3 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual q5min () as needed for chest pain. 2. amlodipine besylate 5 mg tablet sig: two (2) tablet po daily (daily). 3. prazosin hcl 5 mg capsule sig: one (1) capsule po hs (at bedtime). 4. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 5. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 6. metoprolol tartrate 50 mg tablet sig: two (2) tablet po bid (2 times a day). 7. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 9. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po daily (daily) for 30 days. disp:*30 tablet(s)* refills:*3* 10. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 11. tolterodine tartrate 2 mg tablet sig: one (1) tablet po bid (2 times a day). 12. outpatient lab work please check potassium, bun, creatinine and call into nurse practitioner at () - . discharge disposition: home with service facility: vna discharge diagnosis: peripheral vascular disease hyperlipidemia hypertension discharge condition: good, stable. discharge instructions: continue your medications as directed. we have started one new medication called plavix (clopidogrel) that you should take everyday from now on. you will have the other leg fixed on . you do not need to see dr. prior to this. you will see at your primary care doctor's office this tuesday for a blood check. drink plenty of fluids at home. followup instructions: you have an appointment with (nurse practitioner) on tuesday, , at 10:40 a.m. at your primary care doctor's office at (). you should have your blood drawn at that time to check on your kidney. you will also need to see dr. as directed. you are scheduled to have the same procedure on your other leg on . procedure: angioplasty of other non-coronary vessel(s) insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) arteriography of renal arteries diagnoses: pure hypercholesterolemia congestive heart failure, unspecified unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication peripheral vascular disease, unspecified atherosclerosis of renal artery unspecified disorder of kidney and ureter knee joint replacement hip joint replacement 

Answer: The patient is high likely exposed to